Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled studyYameng Sun, Hong You, Cuisong Wu et al.|Hepatology|2025Cited by 10
List of contributorsTanvir Ahmed, Mengchen Lu, Somasundaram Arumugam et al.|Elsevier eBooks|2025Cited by 0